Skip to content
Home/Companies/HealthTech/Agathos

Agathos

HealthTech·US·Exited 2025·Held 7yr
Entry
2018
Hold
7yr
Exit
2025

Who owns Agathos?

Agathos is an American HealthTech company, now owned by EvidenceCare, which acquired it in 2025 from Newfund Management.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Newfund Management
Investor
Newfund Management
Newfund II · 2018 · VC

Key facts

HQUS
SectorHealthTech
StatusActive
Exit Type
Trade Sale
Buyer
EvidenceCare
Exit Year
2025

More from Newfund II

Other portfolio companies in the same fund.

Avanseo
Avanseo
Active
FintechFrance· 2019
Cocoon Space
Cocoon Space
Active
ConsumerFrance· 2019
CoFi
CoFi
Active
FintechUS· 2019
Curv Health
Curv Health
Active
HealthTechUS· 2019
DataGalaxy
DataGalaxy
Active
SaaSFrance· 2019
JobyPepper
JobyPepper
Active
TMTFrance· 2019

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Agathos?

Agathos is now owned by EvidenceCare, which acquired it in 2025 from Newfund Management.

When did EvidenceCare acquire Agathos?

EvidenceCare acquired Agathos in 2025, buying from Newfund Management.

Who did Agathos sell to?

Newfund Management sold Agathos to EvidenceCare in 2025 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue